A Pradaxa wrongful death lawsuit is seeking $1 million in economic and non-economic damages, plus punitive damages against Boehringer Ingelheim. The case, which was originally brought in U.S. District Court for the Northern District of Utah, has been transferred to Illinois federal court where it... Read More

The controversial anticoagulant Pradaxa is at the center of yet more allegations of life-threatening  bleeding events. In a Pradaxa lawsuit filed last month in the U.S. District Court for the Northern District of Georgia, a married couple from Forsyth County, GA, claim that Boehringer Ingelheim,... Read More

Brenda Medley of Missouri has filed a wrongful death lawsuit against Boehringer Ingelheim, the makers of the anti-coagulant drug Pradaxa. This Pradaxa death lawsuit alleges that Boehringer Ingelheim was negligent in warning prescribing physicians and consumers that their product could produce gastrointestinal bleeding, brain hemorrhages,... Read More

The number of Pradaxa lawsuits against the makers of the controversial anticoagulant drug continue to grow as injured plaintiffs seek to hold pharmaceutical giant Boehringer lngelheim responsible for severe bleeding injuries users claim they were not warned could be a side effect of the medication.... Read More

A federal judge recently ruled in favor of manufacturer Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) in a Pradaxa class action lawsuit. After reviewing the pleadings, Judge David Herndon determined that there was insufficient evidence to support many of the plaintiff’s claims, as well as the lawsuit’s... Read More

The controversial anticoagulant Pradaxa has been linked to an increased risk of heart attack in two new studies. News of a Pradaxa heart attack risk comes in the wake of a string of high-profile court cases alleging serious – sometimes fatal – internal bleeding events... Read More

According to a new study published in Circulation, a journal of the American Heart Association, the number of patients who experience Pradaxa bleeding complications increases as patients are given higher dosages of the drug. The study followed up with patients who had participated in a... Read More